China Universal Asset Management Co., Ltd. Krystal Biotech, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 5,526 shares of KRYS stock, worth $1.09 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,526
Previous 3,354
64.76%
Holding current value
$1.09 Million
Previous $615,000
63.25%
% of portfolio
0.11%
Previous 0.09%
Shares
14 transactions
Others Institutions Holding KRYS
# of Institutions
311Shares Held
24.4MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$776 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$560 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$515 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$286 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$194 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.04B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...